chrisvoncsefalvay/vaers-outcomes huggingface dataset:
24 hours the patient had every symptom of covid; Patient got sick; Temperature 100.5; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (24 hours the patient had every symptom of covid), ILLNESS (Patient got sick) and PYREXIA (Temperature 100.5) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (24 hours the patient had every symptom of covid), ILLNESS (Patient got sick) and PYREXIA (Temperature 100.5). At the time of the report, COVID-19 (24 hours the patient had every symptom of covid), ILLNESS (Patient got sick) and PYREXIA (Temperature 100.5) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant products were reported.  The patient got sick in the last week of January of last year. The patient had a temperature of the caller thinks the patient had covid but was not sure. The patient stood on his heads 4 times a day to drain his lungs. 14 months after the patient had the covid virus, he took the Moderna coivd vaccine. The first shot was okay. After the second shot, for 24 hours the patient had every symptom of covid in the book, his temperature was 100.5. The patient never took a covid antibody test to find out if he actually had covid. The patient was over it now and fine.  No treatment information was reported by the reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
On 06/20/2015 I was diagnosed with shingles (herpes zoster). I had been vaccinated with Zostavax in 2010.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reactions for this one seem to be very light) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039F21A) for an unknown indication.  Concomitant products included COLECALCIFEROL (VITAMIN D3), UBIDECARENONE (COQ-10), MAGNESIUM and VITAMIN C [ASCORBIC ACID] for an unknown indication.On 19-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reactions for this one seem to be very light). At the time of the report, VACCINATION COMPLICATION (Reactions for this one seem to be very light) outcome was unknown. No treatment medications were reported. This case was linked to MOD-2021-396066 (Patient Link).
Sore, redness, swollen, hot, itchy and painful to touch. Doctor examined.
With 24 hrs of receiving AFLURIA 0.5ml IM vaccine, patient reports she had several areas of large flat blotchy areas on her face and neck. Also reports itching in the blotchy areas. Used OTC hydrocortisone cream on her own. No other meds. On day 4 symptoms subsiding. No meds nor report to PMD. No fever, no SOB, no muscle aches, no other sx except red blotches.
Tiny red blisters which grew and became itchy and painful.  Took 6 weeks to resolve.  Appeared again couple wks ago. More than before.  They hurt and itch more than before.
Fast heart rate/rapid heartbeat; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 52 year-old female patient received bnt162b2 (BNT162B2), administration date 07Oct2021 (Lot number: PF2589) at the age of 52 years as dose 3 (booster), single for covid-19 immunisation; influenza vaccine (FLU VACCINE VII), administration date 07Oct2021 (Batch/Lot number: unknown) as dose number unknown, single for immunisation. Relevant medical history included: "Hypertension" (unspecified if ongoing), notes: Verbatim: Hypertension. Concomitant medication(s) included: PREMARIN. Vaccination history included: Bnt162b2 (dose: 01), for COVID-19 Immunization; Bnt162b2 (dose: 02), for COVID-19 Immunization. The following information was reported: HEART RATE INCREASED (non-serious) with onset 07Oct2021, outcome "not recovered", described as "Fast heart rate/rapid heartbeat". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of heart rate increased.  Additional information: Patient, female, aged 52, received her booster dose of the Pfizer BioNTech Covid 19 vaccine yesterday between 1pm and 1:45pm along with her flu vaccine. Later in the day while watching the football game she had a fast heart rate and she took something to try to calm down that she takes for her anxiety. She didn't really think anything of it and then went to sleep after the football game. This morning she woke up and while on her pillow it was still kind of rapid but not as rapid as last night. And it wasn't so bad last that that she panicked, she just kept watching the game. She states it was a mild side effect, no tight chest or anything like that. Consumer Stated, "she noticed last night that she had the rapid heartbeat when (incomplete sentence), because she got the Pfizer vaccine yesterday around 1 o'clock she just really noticed that it was the night time and so, she had took one of her 'Calmotin' (Further clarification unknown) which relax you, a little bit. patient took one of her medication that was 'Calmotin' (Further clarification Unknown) that makes her relax and just because she wanted to check that, if for anxiety so it's that to check that she know to see if that help it or not, heart rate 'fell'  Follow-up attempts are completed. No further information is expected.
This case was reported by a physician via sales rep and described the occurrence of tonic-clonic seizures in a 19-year-old male patient who received BEXSERO. The patient's past medical history included cerebral palsy and seizure (but not had one in the past 5 years). On 20th August 2017, the patient received the 1st dose of BEXSERO. On 20th August 2017, less than a day after receiving BEXSERO, the patient experienced tonic-clonic seizures (serious criteria hospitalization and GSK medically significant) and fever (serious criteria hospitalization). The patient was treated with TYLENOL. On 20th August 2017, the outcome of the tonic-clonic seizures was recovered/resolved. On an unknown date, the outcome of the fever was unknown. The reporter considered the tonic-clonic seizures to be possibly related to BEXSERO. It was unknown if the reporter considered the fever to be related to BEXSERO. Additional details were provided as follows: Around midnight of the vaccination day, the patient had a tonic-clonic seizure that lasted for about 10 minutes. His temperature was 37.8 C, but he had been given TYLENOL by his mother earlier. The patient was hospitalized and many tests were performed, but the physicians could not conclusively say the seizure was related to the vaccine.
Moderna vaccine (NDC 80777-0273-98) lot # 039D21A + GTiN 00380777273983 was administered after the beyond date of 10/23/2021. Contacted Manufacturer Moderna = no need to repeat the dose.
Menstrual period started the next day after second dose/ that the period initiated 2 weeks early; Bleeding for 5 days, then stopped; Exhaustion; Chills and exhaustion; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (menstrual period started the next day after second dose/ that the period initiated 2 weeks early), INTERMENSTRUAL BLEEDING (bleeding for 5 days, then stopped), FATIGUE (exhaustion) and CHILLS (chills and exhaustion) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 024C21A and 038B21A) for COVID-19 vaccination.     The patient's past medical history included Endometrial ablation.   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced FATIGUE (exhaustion) and CHILLS (chills and exhaustion). On 06-May-2021, the patient experienced MENSTRUATION IRREGULAR (menstrual period started the next day after second dose/ that the period initiated 2 weeks early) and INTERMENSTRUAL BLEEDING (bleeding for 5 days, then stopped). On 11-May-2021, MENSTRUATION IRREGULAR (menstrual period started the next day after second dose/ that the period initiated 2 weeks early) and INTERMENSTRUAL BLEEDING (bleeding for 5 days, then stopped) had resolved. At the time of the report, FATIGUE (exhaustion) and CHILLS (chills and exhaustion) outcome was unknown.            Treatment medication information were not reported   Most recent FOLLOW-UP information incorporated above includes: On 17-Jun-2021: NNI
Left sided numbness and tingling, and foot drop.diarrhea,  POTS -like elevated heart rate ,itching,weakness ,burning feet and vascular inflammation.  Caused me to have reaction to all usual medications. Swelling on forehead, rash on leg and around mouth. Red fingertips Tinnitus. Lump on neck, ,bright red nose and cheeks.
Client received second dose COVID vaccine @ 10:03 am.  Complained of dizziness and sweaty palms @ 10:15 am while in observation.  Made EMTs aware, placed in zero-gravity chair and vital signs assessed.  Client denied any shortness of breath.  Continued observation and vital signs monitoring.  Client reported decrease in symptoms, and finally resolving @ 10:45 am, nausea continued as a 2/10 on scale.  Client left home, with steady gait, husband with her.  Aware of when to call 911 and follow up with primary care.
Herpes Zoster infection. Prodromal symptoms began approximately 16 hours after administration of second dose of COVID19 vaccine. Rapid onset Saturday morning as diffuse left leg pain, aggravated by movement and weight-bearing, and managed with acetaminophen, ibuprofen, and rest.  Pain progressively worsened over five days. On Day 5 an itching, burning vesicular rash appeared along left low back and wrapping around anteriorly and coursing down leg.  Rash does not cross the midline and follows along the distribution of the L3/L4 dermatome. Diagnosed by pediatrician as Herpes Zoster and treatment with Valacyclovir was initiated. Pain is improving after first 2 days of treatment though rash is still progressing.
-Patient received Pfizer vaccine on 9/23/21.  Patient reports the following adverse reactions: facial swelling/redness and tingling. Tongue tingling and arm redness. No sob or difficulty swallowing. I did have pt wait 30 minutes after the vaccine was given.  Vitals taken and recorded.  Pt was given 25mg of Benadryl after she reported tongue tingling. Pt then returned to the office 30 minutes later with facial edema,redness and tingling. Pt was given another Benedryl 25mg   -Pt was advised to continue to take Benadryl 25-50mg q 4-6 hours as needed. Pt will continue to monitor symptoms and will go to the ER if any difficulty breathing or chest tightness.  Pt was advised to follow up with her PCP tomorrow. Covid Pfizer vaccine added to pt allergy list.
Patient previously received Pfizer (08/05/2021) and Astra zeneca . Patient presented today (08/14/21 )and received Janssen . Patient was monitored for 15 minutes.  No adverse effects noted.
Nausea, unbalance, dizziness, nose bleeds, severe fatigue and drowsiness, shortness of breath, difficulty breathing, irregular heart beat, back pain and discomfort, swelling of face and fainting.
Erythema; Dizziness; Developed, within 20 minutes, quick, fast heartbeat up to 120 beats per minute; Had some irregularity; This spontaneous case was reported by a physician and describes the occurrence of HEART RATE INCREASED (Developed, within 20 minutes, quick, fast heartbeat up to 120 beats per minute), HEART RATE IRREGULAR (Had some irregularity), ERYTHEMA (Erythema) and DIZZINESS (Dizziness) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 16-Feb-2021 at 10:55 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced HEART RATE INCREASED (Developed, within 20 minutes, quick, fast heartbeat up to 120 beats per minute) and HEART RATE IRREGULAR (Had some irregularity). On 17-Feb-2021, the patient experienced ERYTHEMA (Erythema) and DIZZINESS (Dizziness). At the time of the report, HEART RATE INCREASED (Developed, within 20 minutes, quick, fast heartbeat up to 120 beats per minute), HEART RATE IRREGULAR (Had some irregularity), ERYTHEMA (Erythema) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information provided.   Most recent FOLLOW-UP information incorporated above includes: On 25-Feb-2021: No specific follow-up information recorded.
This spontaneous report as received from a nurse refers to a unknown number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On an unknown date the patient were vaccinated with VAQTA. No co-suspect and concomitant therapies were reported. The nurse reported that an unknown number of patients received improperly stored VAQTA, on unknown dates. No adverse symptoms reported. The temperature excursion for VAQTA was found to be a unsupported excursion with in-house stability data. This is one of several reports from the same source. Additional information has been requested.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Oct2022 as dose 5 (booster), single (Lot number: gh9693) at the age of 73 years, in left arm for covid-19 immunisation; bnt162b2 (BNT162B2), on 20Jan2021 as dose 1, single (Lot number: en9581), in left arm, on 20Feb2021 as dose 2, single (Lot number: en6203), in left arm, on 29Sep2021 as dose 3 (booster), single (Lot number: fc3184), in left arm and on 26May2022 as dose 4 (booster), single (Lot number: fc3184), in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Past drug history included: Chrome, reaction(s): "Allergy". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19 included paxlovid from 22Sep2023 to 24Sep2023.
12 x 13 red area over left deltoid and swelling, Temp. 98.8, full range of motion to left shoulder, itching, BP 118/88, P 80 no fever. Treatment Zrytec, Tylenol and ice.
Pt recd 3 doses of Engerix-B vax & 7OCT91 it was determined that pt did not respond to the vax series;
fever, chills x 2 days p/vax still 21AUG97 c/o pain local rxn to immun lt arm 10x9 erythema, warm to touch;
Lightheaded, naseous, stomach pains, and lethargy.; Lightheaded, naseous, stomach pains, and lethargy.; Lightheaded, naseous, stomach pains, and lethargy.; Lightheaded, naseous, stomach pains, and lethargy.; This is a spontaneous report from a noncontactable consumer. This 31-year-old female consumer reported for herself that she received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number/Expiry date: Unknown) via an unspecified route of administration on 26Jan2021 at 10:00 as a 1st dose single for covid-19 immunization. The past medical history and concomitant medications was not reported. The patient was not pregnant at the time of vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 26Jan2021, the patient experienced Lightheaded, naseous, stomach pains, and lethargy. It was unknown if the patient received treatment for the adverse events. On an unknown date, the clinical outcome for the events was recovered in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a nurse practitioner concerning a patient who on an unspecified date was vaccinated with PNEUMOVAX 23 0.5 ml IM (LOT # 664556/1307Y, EXP 21-JAN-2011). The patient experienced injection site swelling and pain. Follow up information from the nurse practitioner who reported that apparently the patient encountered severe injection-site reactions (redness, swelling pain radiating to the armpit and difficulty moving the arm on the patient) after vaccination which eventually improved. The clinic would like Merck to initiate an investigation of this lot but they would not use the lot unless Merck checked it again. This is one of several reports received from the same source. At the time of the report, the patient was recovering. The nurse requested a lot check. A lot check has been initiated. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question (lot # 664556/1307Y) were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Additional information has been requested.
No known adverse effects; administered doses of Rotateq underwent temperature excursion on 10/02/2019 prior to being administered to approximately 8 patients; This non-valid, spontaneous report was received from a registered nurse and refers to an unspecified number of patients of unknown age. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.   On unknown dates, approximately 8 patients were vaccinated with improperly stored doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ), lot # S004251, expiration date 22-SEP-2020 (dose, frequency, route of administration were not provided), for prophylaxis.  Administered doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) experienced the temperature excursion of 47 Fahrenheit degrees (F) for 1 hour. There was no previous temperature excursions reported. The digital data logger was involved to capture the temperature excursion. No adverse effects were reported.  The case is non valid due to lack of the patients' identifiers.
Itchy rash on hands and feet.  Painful hands.  Rash is multiple erythematous edematous papules on hands and elbows.  No fever, joint pains, abdominal pain, nausea, emesis, URI symptoms.
Pain left arm,fever after 24 hrs fatigue,blotting and diarrhea x 2 days
I have been with a shortage of breath, I went to the doctor, they told me I had pneumonia; my lower lung is very inflated. I need to go to another chest x-ray in 3 weeks. I got COVID on Nov 30. I got antibody infusion Dec 3rd. They will do an echo to look at my heart on Thursday 2/24/2022.
I had a n normal immune response at the 24 hour mark. Tired, lethargic, and body aches. I also noticed a golf ball size Hematoma in my left deltoid for two weeks. I have had pain and weakness since. I am noticing marked weakness in my left arm and am unable to lift things if my elbow is not against my body. My chiropractor evaluated me and documented the weakness.
11/25 am, fever 99.6 & increased throughout day. At 6:50 pm, pt had a seizure & taken to ER. Dx'd w/ear infection & tonsillitis but not given med/due to allergies. 11/26, taken to ER, same problem. Child has ear tubes since 7/99.
chills and not feeling very good; chills and not feeling very good; rapid COVID test positive; rapid COVID test positive; This is a spontaneous report from a contactable consumer. This consumer reported similar events for two patients. This is the first of two reports. This case is serious, the other one is non-serious.   A 22-year-old female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EH9899) intramuscular at left deltoid on 22Dec2020 19:00 at single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. No other vaccines given at the same time. The patient received a flu shot back between 27th or 28th Nov2020 in her left deltoid. Caller reported getting the COVID vaccine on the 22Dec2020 and feeling fine before that. On the 28Dec2020 she started feeling chills and not feeling very good and that hasn't gone away. The patient went and got a rapid COVID test and it came back positive, not sure if it was because of the vaccine having antigens in it or she came into contact with it or if she just weakened immune system from the shot. The patient wanted to know if that was true. Then stated she and her mom got the COVID vaccine and her mom received it on the 23Dec. On the 29Dec her whole family started to get sick and experiencing the same things she experienced. The patient was not feeling well at the time of the call. The outcome of the events was not recovered.; Sender's Comments: Linked Report(s) : 2021001266 same reporter/ drug, different patient/event
Patient was given a pediatric Hep B thinking that 2 pediatric doses would equal an adult dose.
Patient received 2nd dose of HPV vaccination. After leaving room patient went to schedule further appointments. Patient developed dizziness, lightheadedness and seeing spots. Patient was lower to floor by mother and a rapid response was called. Patient was monitored by staff and vitals were checked until patient was confident in feeling well.
Area of large local inflammatory redness encompassing entire left upper arm at site of flu vaccine one day prior
once in five years got the flu; Initial information received on 06-Jan-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.   This case involves Adult and unknown gender patient who experienced once in five years got the flu while receiving vaccine INFLUENZA VACCINE.     The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via intra-arterial route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious once in five years got the flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported, "Got ours in Oct. also, always do that most years it works, once in five years got the flu anyway but there's so many strains can't guarantee. Pretty good average, worth it."  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (once in five years got the flu).  At time of reporting, the outcome was Unknown for the event once in five years got the flu.